Cantitate/Preț
Produs

Antiphospholipid Syndrome in Systemic Autoimmune Diseases: Handbook of Systemic Autoimmune Diseases, cartea 12

Editat de R. Cervera, Joan Carles Reverter, Munther Khamashta, Gerard Espinosa
en Limba Engleză Hardback – 28 iun 2016
Antiphospholipid Syndrome in Systemic Autoimmune Diseases, Second Edition provides an overview of our current understanding of this major disease. It includes the latest information on the new pathogenetic mechanisms involved, along with clinical manifestations in both the thrombotic and non-thrombotic manifestations of this important disease.
Antiphospholipid syndrome is an autoimmune disease that causes abnormal blood clots. It is now recognized as a major cause of common conditions, including stroke, heart attack, miscarriage, epilepsy, and memory loss, and as such is gaining recognition in all branches of medicine, from obstetrics to cardiology, and from psychiatry to orthopedics.


  • Brings the reader up-to-date and allows easy access to individual topics in one place
  • Written by a respected panel of distinguished physicians/scientists actively involved in the field of Antiphospholipid Syndrome
  • Includes box summaries at the end of each chapter that highlight important topics
  • Gives up-to-date, basic knowledge and a modern approach to diagnosis and therapy
  • Provides a comprehensive review of this major disease
  • Includes information on treatment options available
Citește tot Restrânge

Din seria Handbook of Systemic Autoimmune Diseases

Preț: 77978 lei

Preț vechi: 97780 lei
-20% Nou

Puncte Express: 1170

Preț estimativ în valută:
14923 15502$ 12396£

Carte tipărită la comandă

Livrare economică 27 ianuarie-10 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780444636553
ISBN-10: 0444636552
Pagini: 326
Dimensiuni: 152 x 229 x 32 mm
Greutate: 0.66 kg
Ediția:2
Editura: ELSEVIER SCIENCE
Seria Handbook of Systemic Autoimmune Diseases


Cuprins

1. History, Classification, and Subsets of the Antiphospholipid Syndrome2. Epidemiology of the Antiphospholipid Syndrome3. Mechanisms of Action of the Antiphospholipid Antibodies4. Laboratory Markers With Clinical Significance in the Antiphospholipid Syndrome5. Genetic and Epigenetic Aspects of Antiphospholipid Syndrome: What we knew, what we know6. Thrombotic Manifestations of the Antiphospholipid Syndrome7. Obstetric Manifestations of the Antiphospholipid Syndrome8. Thrombocytopenia in the Antiphospholipid Syndrome9. Nonclassification Criteria Manifestations of the Antiphospholipid Syndrome10. Paediatric Antiphospholipid Syndrome11. Antiphospholipid Antibodies and Their Relationship With Infections, Vaccines, and Drugs12. Antiphospholipid Syndrome Associated With Malignancies13. Antiphospholipid Antibodies and Atherosclerosis14. Global Antiphospholipid Syndrome Score15. Primary Prophylaxis in Patients With Positive Antiphospholipid Antibodies16. Treatment of Thrombosis in Antiphospholipid Syndrome17. Treatment of Catastrophic Antiphospholipid Syndrome18. Treatment of Pregnancy Complications in Antiphospholipid Syndrome19. Prognosis in Antiphospholipid Syndrome